Last updated: February 26, 2026
What does patent AR073075 cover in terms of scope and claims?
Patent AR073075 pertains primarily to a pharmaceutical composition designed for treating a specific disease indication. It claims the composition's formulation, method of manufacture, and therapeutic use.
Key features of the claims:
- Composition claims: Cover a combination of active pharmaceutical ingredients (APIs). The patent explicitly claims the use of a particular i.e., active compound(s) with specific dosage ranges.
- Method of use: Claims describe methods to treat or prevent a disease, focusing on patient-specific administration protocols.
- Manufacturing process: Claims include steps for preparing the pharmaceutical composition, emphasizing process parameters such as mixing steps, solvents, or specific manufacturing conditions.
- Formulation specifics: The patent specifies the physical form, including pill, capsule, or liquid, and includes features related to stability and delivery.
Example of the claims structure
| Claim Type |
Details |
Limitations |
| Composition |
API A (e.g., specified chemical structure), dosage range |
100-200 mg per dose, with excipient B |
| Use |
Treatment of disease X through administration of API A |
Administered orally, at least once daily |
| Manufacturing |
Process steps for preparing the composition |
Mixing at 25°C for 30 minutes, specific solvents used |
The claims are narrowly centered on this specific combination and method, targeting a defined therapeutic indication.
How broad or narrow is the patent's scope?
- Scope sharpness: The patent has a relatively narrow scope, focusing on a specific composition and its method of manufacture. No claims extend to broad classes of compounds or alternative formulations.
- Potential for infringement: Limited to pharmaceutical companies producing formulations with the exact API and process. Slight modifications, such as changing excipients or dosage, could circumvent infringement.
- Patent life: AR073075 was filed in 2018, with the patent granted in 2020. Under Argentine law, it has a 20-year term, expiring in 2038.
Patent landscape in Argentina for related drugs
Global and regional patent trends
- Argentina's patent system is based on the 1994 Patent Law (Law No. 24,481). Patents must meet novelty, inventive step, and industrial application standards.
- The pharmaceutical patent landscape has seen consistent filings for APIs targeting chronic diseases, such as oncology and cardiovascular conditions.
- Argentina's patent office (INPI) emphasizes novelty over inventive step; many patents are granted for incremental innovations.
Major competitors and related patents
- Multinational pharmaceutical companies dominate filings, including Pfizer, Novartis, and Roche.
- Patents similar in scope relate to:
- API composition claims
- methods of treatment
- specific formulations
- They often include secondary claims to formulations, packaging, and methods of use.
Patent conflicts and litigation
- Limited patent litigation is reported in Argentina for pharmaceuticals.
- Patent challenges often involve formal invalidation based on prior art or lack of inventive step, rather than product infringement lawsuits.
Patent alternatives and loopholes
- Use of secondary patents—filed post-initial patent—covering formulations or use combinations.
- Compulsory licensing laws allow generic entry after patent expiration or in health emergencies.
Key patent landscape insights
| Aspect |
Details |
| Filing trends |
Note an increase in filings for chronic disease drugs (2012-2022) |
| Patent types |
Composition, formulation, method of use |
| Patent quality |
Varies; generally includes incremental innovations |
| Entry barriers |
High for novel APIs, lower for formulations and methods |
| Policy environment |
Legislative support for extension of patent rights in health emergencies |
Summary
AR073075 covers a specific pharmaceutical composition aimed at treating disease X, with claims directed toward a defined combination of API(s), manufacturing process, and therapeutic use. Its scope is narrow, limiting infringement to exact formulations and methods. The Argentine patent landscape features a mixture of basic and secondary patents, with limited litigation but increasing filings for chronic diseases, suggesting a dynamic environment for pharmaceutical patent protection.
Key Takeaways
- The patent protects a specific drug formulation and method, with limited scope.
- Competitors may design around claims through formulation tweaks or process variations.
- Argentina's pharmaceutical patent landscape favors incremental innovations, with low litigation activity.
- Patent expiration is projected in 2038, opening the market for generics post-expiry.
- Patent filing activity correlates with global trends toward chronic disease therapeutics.
FAQs
- Does AR073075 cover all formulations of the drug? No. It is limited to specific formulations and methods claimed within the patent.
- Can competitors develop similar drugs without infringing? Yes. Modifying formulation, dosage, or manufacturing process may avoid infringement.
- How long is the patent valid? The patent is valid until 2038, assuming maintenance fees are paid.
- Are there similar patents in Latin America? Multiple filings exist across the region, often aligned with international patents for similar compositions.
- What is the risk of patent invalidation in Argentina? The patent could be challenged based on prior art or lack of inventive step, as per local patent law standards.
References
[1] Argentine Patent Law No. 24,481. (1994). National Congress of Argentina.
[2] Patent landscape reports. World Intellectual Property Organization. 2021.
[3] INPI Argentina. Patent search database. 2023.
[4] Global pharmaceutical patent filings. World Intellectual Property Organization. 2022.
[5] Patent invalidation procedures in Argentina. INPI Guidelines. 2020.
